You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Von Hippel-Lindau Disease

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Neoplasms Including Adrenocortical Carcinoma

Recruiting
  • Neuroendocrine Tumors
  • Carcinoma, Neuroendocrine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Diabetic Foot Ulcer Trial (Deferoxamine, Placebo)

    Not yet recruiting
    • Diabetic Foot Ulcer
    • (no location specified)
    May 25, 2022

    Polycythemia; Familial, Erythrocytosis; Familial, VHL Gene Mutation Trial (Digoxin)

    Not yet recruiting
    • Polycythemia; Familial
    • +5 more
    • (no location specified)
    Feb 2, 2022

    Renal Tumor Trial (Robotic-assisted laparoscopic partial nephrectomy (LPN) or laparoscopic nephrectomy (LN))

    Not yet recruiting
    • Renal Tumor
    • Robotic-assisted laparoscopic partial nephrectomy (LPN) or laparoscopic nephrectomy (LN)
    • (no location specified)
    May 15, 2022

    Von Willebrand Diseases Trial in United States (recombinant von Willebrand factor, tranexamic acid)

    Active, not recruiting
    • Von Willebrand Diseases
    • recombinant von Willebrand factor
    • tranexamic acid
    • Gilbert, Arizona
    • +18 more
    Jan 26, 2023

    Cardiovascular and Venous Thromboembolism Disease in Von

    Active, not recruiting
    • Von Willebrand Diseases
      • Angers, France
      • +5 more
      Mar 6, 2023

      Von Willebrand Disease, Type 1, Heavy Menstrual Bleeding Trial (Volta System)

      Not yet recruiting
      • Von Willebrand Disease, Type 1
      • Heavy Menstrual Bleeding
      • Volta System
      • (no location specified)
      Sep 26, 2023

      Certain Adverse Events in Von Willebrand Disease Treated With

      Recruiting
      • Von Willebrand Disease (VWD)
        • Bad Homburg vor der Höhe, Hessen, Germany
          MVZ Gerinnungszentrum Hochtaunus
        Aug 22, 2022

        Molecular Biology of Polycythemia and Thrombocytosis

        Recruiting
        • Polycythemia
        • Thrombocytosis
          • Salt Lake City, Utah
            University of Utah
          Dec 28, 2022

          Von Willebrand Diseases Trial in Vienna (VGA039, Placebo)

          Recruiting
          • Von Willebrand Diseases
          • Vienna, Austria
            Medical University of Vienna
          Mar 20, 2023

          Type 3 Von Willebrand International Registries Inhibitor

          Active, not recruiting
          Has Results
          • Type 3 Von Willebrand's Disease
          • Von Willebrand Factor
          • Helsinki, Finland
          • +24 more
          Mar 21, 2022

          The Lived Experience of People With Von Willebrand Disease

          Not yet recruiting
          • Von Willebrand Diseases
          • Online Survey
          • +2 more
          • (no location specified)
          Oct 3, 2023

          Bleeding Disorder Trial in Charlottesville (Recombinant von Willebrand Factor)

          Not yet recruiting
          • Bleeding Disorder
          • Recombinant von Willebrand Factor
          • Charlottesville, Virginia
            UVA Hospital
          Nov 3, 2023

          Renal Cell Carcinoma Trial in Philadelphia (drug, genetic, other, procedure)

          Terminated
          Has Results
          • Renal Cell Carcinoma
          • Brivanib alaninate
          • +5 more
          • Philadelphia, Pennsylvania
            Abramson Cancer Center of the University of Pennsylvania
          Mar 18, 2021

          Von Willebrand Disease Trial (Alphanate SD/HT)

          Active, not recruiting
          • Von Willebrand Disease
          • Alphanate SD/HT
          • (no location specified)
          May 5, 2022

          Von Willebrand Disease Trial in Spain (plasma-derived FVIII/VWF concentrate)

          Recruiting
          • Von Willebrand Disease
          • plasma-derived FVIII/VWF concentrate
          • Esplugues De Llobregat, Barcelona, Spain
          • +3 more
          Feb 4, 2022

          Von Willebrand Disease, Type 2B Trial in Caen (3T (Tesla) Magnetic Resonance Imaging (MRI))

          Recruiting
          • Von Willebrand Disease, Type 2B
          • 3T (Tesla) Magnetic Resonance Imaging (MRI)
          • Caen, Calvados, France
            University Hospital
          Aug 19, 2021

          Kidney Cancer Trial in Los Angeles (bortezomib)

          Completed
          Has Results
          • Kidney Cancer
          • Los Angeles, California
            Jonsson Comprehensive Cancer Center at UCLA
          Aug 17, 2020

          Iron Deficiency Trial in Oxford (Ferric carboxymaltose, Sodium chloride ())

          Completed
          • Iron Deficiency
          • Ferric carboxymaltose
          • Sodium chloride (placebo)
          • Oxford, Oxfordshire, United Kingdom
            University of Oxford OCMR & CCRF, John Radcliffe Hospital
          Jul 15, 2022

          Von Willebrand Disease (VWD) Trial (Recombinant von Willebrand Factor (rVWF), ADVATE)

          Not yet recruiting
          • Von Willebrand Disease (VWD)
          • Recombinant von Willebrand Factor (rVWF)
          • ADVATE
          • (no location specified)
          Oct 14, 2022

          Von Willebrand Diseases, Postpartum Hemorrhage Trial in Pittsburgh (Recombinant Von Willebrand factor, Tranexamic Acid Injection

          Recruiting
          • Von Willebrand Diseases
          • Postpartum Hemorrhage
          • Recombinant Von Willebrand factor
          • Tranexamic Acid Injection [Cyklokapron]
          • Pittsburgh, Pennsylvania
          • +1 more
          Jul 5, 2022

          Nivolumab in mRCC Patients: Treg Function, T-cell Access and NK

          Recruiting
          • RCC
          • Metastatic Renal Cell Carcinoma
          • Immunological and tumour characterization
          • Naples, Italy
            IRCCS Istituto Nazionale Tumori di Napoli
          Sep 10, 2020

          VWD - Von Willebrand's Disease Trial in Wellington

          Recruiting
          • VWD - Von Willebrand's Disease
            • Wellington, Florida
              VWD Connect Foundation
            Jun 24, 2022

            Patients With Von WilLEbrand Disease Treated With Voncento®

            Active, not recruiting
            • Von Willebrand Disease
            • Voncento®
            • Besançon, France
            • +16 more
            Jan 10, 2022

            Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia Trial in Peoria (Emicizumab)

            Not yet recruiting
            • Von Willebrand Disease, Type 3
            • Concomitant VWD and Hemophilia
            • Peoria, Illinois
              Bleeding and Clotting Disorders Institute
            Aug 12, 2022